Aeonian Biotech

Aeonian Biotech is a Netherlands-based biotechnology company specializing in the provision of high-quality, selectivity-validated antibodies for the global research and diagnostic markets. The company addresses the reproducibility crisis in life sciences by implementing rigorous validation protocols to ensure their antibodies are specific to their intended targets with minimal cross-reactivity. Their extensive catalog covers a wide range of therapeutic areas, including oncology, neuroscience, and cardiovascular diseases, offering both monoclonal and polyclonal options. Aeonian Biotech primarily serves academic researchers, pharmaceutical companies, and diagnostic developers seeking reliable reagents for applications such as immunohistochemistry and western blotting. By providing transparent validation data, the company aims to improve the reliability of proteomic research and drug discovery workflows.